LSR,study_name,year,n_randomised,treatment_details,treatment,age_mean,female_n,dose_delivered_min,dose_delivered_mean,dose_delivered_max,dose_planned_min,dose_planned_max,tx_duration,study_duration,r_acceptability,r_tolerability,anhedonia_baseline_scale,anhedonia_baseline_direction,anhedonia_baseline_n,anhedonia_baseline_mean,anhedonia_baseline_sd,anhedonia_followup_scale,anhedonia_followup_direction,anhedonia_followup_n,anhedonia_followup_mean,anhedonia_followup_sd,anhedonia_followup_type,anhedonia_followup_time,anxiety_baseline_scale,anxiety_baseline_direction,anxiety_baseline_n,anxiety_baseline_mean,anxiety_baseline_sd,anxiety_followup_scale,anxiety_followup_direction,anxiety_followup_n,anxiety_followup_mean,anxiety_followup_sd,anxiety_followup_type,anxiety_followup_time,reward_baseline_scale,reward_baseline_direction,reward_baseline_n,reward_baseline_mean,reward_baseline_sd,reward_followup_scale,reward_followup_direction,reward_followup_n,reward_followup_mean,reward_followup_sd,reward_followup_type,reward_followup_time,AE,female_prop,arm,treatment_old,nausea,headache,insomnia,dry_mouth,constipation,dizziness,vomiting,arm_name,main,study_design,drug_name,dose,population,state,sample_n,randomized_n,female_n,duration_weeks,response_e,response_n,relapse_e,relapse_n,dropout_any_e,dropout_any_n,dropout_ae_e,dropout_ae_n,death_e,death_n,serious_e,serious_n,D1,D2,D3,D4,D5,Overall,overall_scale_name,overall_n,overall_baseline,overall_mean,overall_sd,overall_change_endpoint,overall_completer,overall_sd_origin,positive_scale_name,positive_n,positive_baseline,positive_mean,positive_sd,positive_change_endpoint,positive_completer,positive_sd_origin,negative_scale_name,negative_n,negative_baseline,negative_mean,negative_sd,negative_change_endpoint,negative_completer,negative_sd_origin,functioning_scale_name,functioning_n,functioning_baseline,functioning_mean,functioning_sd,functioning_change_endpoint,functioning_completer,functioning_sd_origin,cognition_scale_name,cognition_n,cognition_baseline,cognition_mean,cognition_sd,cognition_change_endpoint,cognition_completer,cognition_sd_origin,depression_scale_name,depression_n,depression_baseline,depression_mean,depression_sd,depression_change_endpoint,depression_completer,depression_sd_origin,weight_scale_name,weight_n,weight_baseline,weight_mean,weight_sd,weight_change_endpoint,weight_completer,weight_sd_origin,Timepoint,prolactin_scale_name,prolactin_n,prolactin_baseline,prolactin_mean,prolactin_sd,prolactin_change_endpoint,prolactin_completer,prolactin_sd_origin,adverse_event_e,adverse_event_n,anticholinergic_symptom_e,anticholinergic_symptom_n,anxiety_e,anxiety_n,dizziness_e,dizziness_n,headache_e,headache_n,nausea_vomitting_e,nausea_vomitting_n,sedation_e,sedation_n,hyperprolactinemia_e,hyperprolactinemia_n,qtc_prolongation_e,qtc_prolongation_n,agitation_e,agitation_n,hypotension_e,hypotension_n,insomnia_e,insomnia_n,akathisia_e,akathisia_n,eps_symptoms_e,eps_symptoms_n,weight_increased_e,weight_increased_n,drug_new,timepoint,comparison_data
1,UK Moclobomide Study Group (1994),1994,56,,moclobemide,NA,NA,NA,NA,450,450,450,6,6 weeks,27,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Manic=2;Dry mouth=15;Constipation=7;Suicide=1;Sweating=2,NA,active,moclobemide,NA,NA,NA,15,7,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,UK Moclobomide Study Group (1994),1994,54,,placebo,NA,NA,NA,NA,NA,NA,NA,6,6 weeks,29,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Manic=1;Dry mouth=14;Constipation=6;Suicide=1;Sweating=6,NA,placebo,placebo,NA,NA,NA,14,6,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Agosti (1991) - 87999115,1991,10,,phenelzine,NA,NA,NA,NA,NA,60,90,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,phenelzine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Agosti (1991) - 87999115,1991,12,,selegiline,NA,NA,40,NA,40,40,40,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,selegiline (l-deprenyl),NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Agosti (1991) - 87999115,1991,23,,placebo,NA,NA,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Amsterdam (1989) - 90055468,1989,34,,minaprine,41,12,NA,93,NA,100,400,4,NA,14,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3529411765,active,minaprine 100mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Amsterdam (1989) - 90055468,1989,39,,minaprine,37,25,NA,186,NA,100,400,4,NA,16,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.641025641,active,minaprine 200mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Amsterdam (1989) - 90055468,1989,43,,minaprine,40,22,NA,279,NA,100,400,4,NA,23,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.511627907,active,minaprine 300mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Amsterdam (1989) - 90055468,1989,37,,minaprine,37,22,NA,352,NA,100,400,4,NA,14,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5945945946,active,minaprine 400mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Amsterdam (1989) - 90055468,1989,37,,placebo,39,18,NA,NA,NA,NA,NA,4,NA,12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4864864865,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Amsterdam (2003) - 87998463,2003,149,,selegiline,41.2,94,NA,NA,NA,20,20,8,"8 weeks. [{'ItemDocumentId': 1050661, 'TextFrom': 0, 'TextTo': 0, 'Text': 'Page 2:\n[¬s]""8-week clinical trial[¬e]""', 'IsFromPDF': True, 'DocTitle': 'Amsterdam Jay D - 2003 - A double-blind, placebo-controlled trial of the sa.pdf', 'ItemArm': ''}]",41,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Body as a whole=25;Asthenia=5;Headache=17;Pain abdominal=1;Cardiovascular=6;Digestive=19;Diarrhea=8.00;Dyspepsia=2;Nausea=6;Metabolic and nutritional=5;Nervous=29;Anxiety=1;Dizziness=6;Dry mouth=8;Insomnia=11;Somnolence=3;Respiratory=5;Skin=56;Application-site reaction=47;Rash=5;Special sense=9;Urogenital=3,0.6308724832,active,selegiline,6,17,NA,8,NA,6,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Amsterdam (2003) - 87998463,2003,152,,placebo,43.5,99,NA,NA,NA,NA,NA,8,"8 weeks. [{'ItemDocumentId': 1050661, 'TextFrom': 0, 'TextTo': 0, 'Text': 'Page 2:\n[¬s]""8-week clinical trial[¬e]""', 'IsFromPDF': True, 'DocTitle': 'Amsterdam Jay D - 2003 - A double-blind, placebo-controlled trial of the sa.pdf', 'ItemArm': ''}]",41,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Body as a whole=34.00;Asthenia=5;Headache=19.00;Pain abdominal=6;Cardiovascular=4;Digestive=20  ;Diarrhea=9;Dyspepsia=5;Nausea=6;Metabolic and nutritional=6;Nervous=34;Anxiety=7;Dizziness=4;Dry mouth=8;Insomnia=6;Somnolence=5;Respiratory=4;Skin=26;Application-site reaction=23;Rash=1;Special sense=6;Urogenital=5,0.6513157895,placebo,placebo,6,19,NA,8,NA,4,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bakish (1992) - 87999050,1992,58,,moclobemide,42,26,NA,492,600,NA,600,6,NA,17,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4482758621,active,moclobemide,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bakish (1992) - 87999050,1992,56,,placebo,44,20,NA,NA,NA,NA,NA,6,NA,27,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3571428571,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bellak (1966) - 87999673,1966,25,,phenelzine,NA,NA,NA,NA,NA,NA,NA,NA,18 months,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,phenelzine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bellak (1966) - 87999673,1966,25,,placebo,NA,NA,NA,NA,NA,NA,NA,NA,18 months,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Benes (2011) - 87997624,2011,198,Ropinirole,ropinirole,58.2,144,NA,1.9,NA,0.5,4,12,18 months,54,35,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Nausea=64
Headache=39
Fatigue=25
Dizziness=17
Vomiting=14
Abdominal pain=7
Hyperhidrosis=7
Diarrhea=6
Peripheral edema=6",0.7272727273,active,ropinirole,64,39,NA,NA,NA,17,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Benes (2011) - 87997624,2011,67,Placebo,placebo,59.5,45,NA,NA,NA,NA,NA,12,18 months,29,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Nausea=5
Headache=9
Fatigue=4
Dizziness=2
Vomiting=0
Abdominal pain=0
Hyperhidrosis=1
Diarrhea=0
Peripheral edema=1",0.671641791,placebo,placebo,5,9,NA,NA,NA,2,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bodkin (2002) - 89915354,2002,89,,selegiline,41.4,53,NA,20,20,NA,20,6,NA,10,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Any adverse event=78; Body as a whole=40; Headache=20; Infection=8; Back pain=5; Pain=4; Abdominal pain=3; Cardiovascular=3; Hypertension=0; Postural hypotension=1; Palpitations=0; Tachycardia=1; Skin=39; Application site reaction=32; Nervous=25; Dizziness=7; Insomnia=6; Somnolence=6; Depression=1; Digestive=23; Diarrhea=8; Dry mouth=8; Flatulence=5; Dyspepsia=3; Respiratory=14; Pharyngitis=5; Sinusitis=5; Rhinitis=4; Urogenital=12; Urinary tract infection=6; Musculoskeletal=4; Myalgia=2,0.595505618,active,selegiline,NA,20,6,8,NA,7,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bodkin (2002) - 89915354,2002,88,,placebo,43.2,53,NA,NA,NA,NA,NA,6,NA,15,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Any adverse event=69; Body as a whole=36; Headache=19; Infection=2; Back pain=3; Pain=6; Abdominal pain=5; Cardiovascular=6; Hypertension=1; Postural hypotension=2; Palpitations=1; Tachycardia=0; Skin=21; Application site reaction=15; Nervous=28; Dizziness=5; Insomnia=6; Somnolence=4; Depression=5; Digestive=26; Diarrhea=9; Dry mouth=6; Flatulence=2; Dyspepsia=6; Respiratory=16; Pharyngitis=7; Sinusitis=1; Rhinitis=6; Urogenital=10; Urinary tract infection=5; Musculoskeletal=7; Myalgia=5,0.6022727273,placebo,placebo,NA,19,6,6,NA,5,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Botte (1992) - 87999081,1992,23,Moclobemide,moclobemide,51.39,13,200,NA,600,300,600,6,6 weeks,3,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Insomnia=4;
Increased anxiety=2;
Dyspepsia=2;
Diarrhea=2;
Agitation=1;
Weight gain=1;
Dizziness=1;
Headache=1;
Blurred vision=1;
Constipation=1;
Menstrual disturbances=1;",0.5652173913,active,moclobemide,NA,1,4,NA,NA,1,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Botte (1992) - 87999081,1992,24,Placebo,placebo,43.33,16,NA,NA,NA,NA,NA,6,6 weeks,12,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Dyspepsia=1;
Increased anxiety=1;
Sweating=1;
Hypotension=2;
Tiredness=1;",0.6666666667,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bymaster (2011) - 90051758,2011,34,Amitifadine,amitifadine,48.2,25,25,NA,50,50,50,6,8months,18,3,MADRS Anhedonia factor,negative,33,12.7,2.1,MADRS Anhedonia factor,negative,30,7.9,2.74,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=3;Abdominal pain=2;Anxiety=2;Diarrhea=2;Irritability=2;Nausea=2;Rash=2;Upper respiratory tract infection=2;emotional disturbance=2,0.7352941176,active,amitifadine,2,3,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Bymaster (2011) - 90051758,2011,29,Placebo,placebo,49.5,19,NA,NA,NA,NA,NA,6,8months,12,3,MADRS Anhedonia factor,negative,28,13.7,1.6,MADRS Anhedonia factor,negative,26,9.3,1.58,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=3;Abdominal pain=1;Anxiety=1;Diarrhea=1;Irritability=1;Nausea=1;Rash=1;Upper respiratory tract infection=1;,0.6551724138,placebo,placebo,1,3,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Casacchia (1984) - 87999374,1984,18,Moclobemide,moclobemide,49.5,8,150,297.2,450,NA,NA,4,NA,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HRSD - psychic anxiety item,negative,18,2.77,0.64,HRSD - psychic anxiety item,negative,18,1.38,1,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Diurnal somnolence=1;trembling=2;dry mouth=1;constipation=1,0.4444444444,active,moclobemide,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Casacchia (1984) - 87999374,1984,16,Placebo,placebo,49,11,150,212.5,400,NA,NA,4,NA,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HRSD - psychic anxiety item,negative,16,2.43,1.03,HRSD - psychic anxiety item,negative,16,2.06,0.93,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Sleep disturbances=1;dry mouth=1,0.6875,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Chouinard (1993) - 87999011,1993,111,*Brofaromine,brofaromine,41.2,57,NA,NA,NA,75,150,6,16 months,43,16,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAMD- Anxiety item,negative,111,7.6,NA,HAMD- Anxiety item,negative,111,4.9,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=53;Nausea=41;Dizziness=26;Insomnia=26;Dry mouth=22;Constipation=16;Diarrhea=15;Flatulence=8;Stomach upset=5;Fatigue=5,0.5135135135,active,brofaromine,41,53,26,22,16,26,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Chouinard (1993) - 87999011,1993,109,Placebo,placebo,40.2,66,NA,NA,NA,NA,NA,6,16 months,52,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAMD- Anxiety item,negative,109,7.5,NA,HAMD- Anxiety item,negative,109,5,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=56;Nausea=28;Dizziness=15;Insomnia=14;Dry mouth=5;Constipation=12;Diarrhea=14;Flatulence=3;Stomach upset=10;Fatigue=5,0.6055045872,placebo,placebo,28,56,14,5,12,15,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Coleman (1999) - 87998674,1999,122,*bupropion SR,bupropion,38.1,68,100,290,365,150,400,8,NA,27,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,122,NA,NA,HAM-A,negative,NA,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=40;
Nausea=23;
Dry mouth=21;
Diarrhea=14;
Dyspepsia=9;
Insomnia=24;
Agitation=14;
Rhinitis=9;",0.5573770492,active,bupropion sr,23,40,NA,21,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Coleman (1999) - 87998674,1999,124,Placebo,placebo,38.5,73,NA,NA,NA,NA,NA,8,NA,40,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,124,NA,NA,HAM-A,negative,NA,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=32;
Nausea=14;
Dry mouth=19;
Diarrhea=17;
Dyspepsia=8;
Insomnia=8;
Agitation=4;
Rhinitis=11;",0.5887096774,placebo,placebo,14,32,NA,19,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Coleman (2001) - 87998563,2001,150,,bupropion,36.6,95,NA,NA,NA,150,400,8,8 weeks,56,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=42;
Dry mouth=44;
Nausea=32;
Agitation=17;
Insomnia=21;
Diarrhea=13;
Somnolence=4;",0.6333333333,active,bupropion,32,42,21,44,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Coleman (2001) - 87998563,2001,152,,placebo,36.7,92,NA,NA,NA,NA,NA,NA,8 weeks,50,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6.8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=31;
Dry mouth=22;
Nausea=24;
Agitation=21;
Insomnia=10;
Diarrhea=13;
Somnolence=6;",0.6052631579,placebo,placebo,24,31,10,22,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Corrigan (2000) - 90044744,2000,36,,pramipexole,NA,NA,0.375,0.375,0.375,0.375,0.375,8,9 weeks,9,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,headache=12;nausea=9;somnolence=4;dizziness=5;insomnia=5;infection=5;asthenia=4;anorexia=1;vomiting=0,NA,active,pramipexole 0.375mg,9,12,5,NA,NA,5,0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Corrigan (2000) - 90044744,2000,35,,pramipexole,NA,NA,1,1,1,1,1,8,9 weeks,12,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,headache=15;nausea=16;somnolence=6;dizziness=6;insomnia=4;infection=7;asthenia=2;anorexia=5;vomiting=4,NA,active,pramipexole 1mg,16,15,4,NA,NA,6,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Corrigan (2000) - 90044744,2000,33,,pramipexole,NA,NA,5,5,5,5,5,8,9 weeks,19,17,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,headache=10;nausea=25;somnolence=12;dizziness=9;insomnia=5;infection=1;asthenia=5;anorexia=4;vomiting=13,NA,active,pramipexole 5mg,25,10,5,NA,NA,9,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Corrigan (2000) - 90044744,2000,35,,placebo,NA,NA,NA,NA,NA,NA,NA,8,9 weeks,11,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,headache=11;nausea=7;somnolence=2;dizziness=3;insomnia=1;infection=6;asthenia=0;anorexia=1;vomiting=2,NA,placebo,placebo,7,11,1,NA,NA,3,2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Croft (1999) - 87998692,1999,120,*bupropion SR,bupropion,35.9,61,127,293,361,150,400,8,NA,36,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,120,NA,NA,HAM-A,negative,NA,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Nausea=21;Diarrhea=8;Dry mouth=22;Headache=40;Insomnia=15;Somnolence=4,0.5083333333,active,bupropion sr,21,40,NA,22,15,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Croft (1999) - 87998692,1999,121,Placebo,placebo,37.4,61,NA,NA,NA,NA,NA,8,NA,41,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,121,NA,NA,HAM-A,negative,NA,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Nausea=12;Diarrhea=13;Dry mouth=14;Headache=36;Insomnia=5;Somnolence=7,0.5041322314,placebo,placebo,12,36,NA,14,5,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Davidson (1988) - 87999240,1988,68,Isocarboxazid,isocarboxazid,41.9,37,NA,49.3,NA,NA,NA,6,NA,39,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Covi Anxiety Scale Total,negative,68,10.23,NA,Covi Anxiety Scale Total,negative,48,5.61,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5441176471,active,isocarboxazid,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Davidson (1988) - 87999240,1988,62,Placebo,placebo,41.9,35,NA,NA,NA,NA,NA,6,NA,52,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Covi Anxiety Scale Total,negative,62,9.88,NA,Covi Anxiety Scale Total,negative,36,7.46,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.564516129,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,DelBello (2014) - 87997132,2014,152,,selegiline,14.8,93,NA,NA,NA,6,12,12,12 weeks,51,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Gastrointestinal disorders=31;Abdominal pain=3;Abdominal pain upper=4;Diarrhea=5;Nausea=11;Vomiting=7;General disorders & administration site conditions=42
Application site reaction=37;Fatigue=4;Infections and infestations=18;Nasopharyngitis=6;Metabolism and nutrition disorders=6;Decreased appetite =5;Musculoskeletal & connective tissue disorders=13;Back pain=4;Nervous system disorders=41;Dizziness=8;Headache=26;Somnolence=7;Psychiatric disorders=24;Agitation=4;Anxiety=4;Insomnia=9;Irritability=2;Suicidal ideation=4;Respiratory, thoracic & mediastinal disorders=25;Pharyngolaryngeal pain=4;Upper respiratory tract infection=11",0.6118421053,active,selegiline,11,26,9,NA,NA,8,7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,DelBello (2014) - 87997132,2014,156,,placebo,14.7,104,NA,NA,NA,NA,NA,8,12 weeks,42,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Gastrointestinal disorders=31;Abdominal pain=4;Abdominal pain upper=7;Diarrhea=7;Nausea=12;Vomiting=4;General disorders & administration site conditions=42;Application site reaction=34;Fatigue=4;Infections and infestations=18;Nasopharyngitis=7;Metabolism and nutrition disorders=4;Decreased appetite =2;Musculoskeletal & connective tissue disorders=9;Back pain=4;Nervous system disorders=11;Dizziness=7;Headache=26;Somnolence=4;Psychiatric disorders17;Agitation=3;Anxiety=2;Insomnia=4;Irritability=4;Suicidal ideation=4;Respiratory, thoracic & mediastinal disorders=12;Pharyngolaryngeal pain=3;Upper respiratory tract infection=4",0.6666666667,placebo,placebo,12,26,4,NA,NA,7,4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Feiger (2006) - 87998150,2006,132,Selegiline,selegiline,42,81,6,NA,12,6,12,8,8 weeks,32,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Application-site reaction=53;Insomnia=40;Infection=18;Dizziness=17;Dry mouth=16;Nervousness=13;Diarrhea=13,0.6136363636,active,selegiline transdermal system,NA,NA,40,16,NA,17,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Feiger (2006) - 87998150,2006,133,,placebo,42,71,NA,NA,NA,NA,NA,8,8 weeks,27,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Application-site reaction=27;Insomnia=19;Infection=17;Dizziness=9;Dry mouth=10;Nervousness=8;Diarrhea=5,0.5338345865,placebo,placebo,NA,NA,19,10,NA,9,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Feighner (1984) - 87999367,1984,44,,bupropion,43.9,30,300,392,600,NA,600,4,NA,10,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6818181818,active,bupropion,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Feighner (1984) - 87999367,1984,22,,placebo,49,19,NA,NA,NA,NA,NA,4,NA,7,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.8636363636,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Georgotas (1986) - 87999298,1986,22,,phenelzine,65.5,13,NA,53.9,NA,NA,NA,7,NA,4,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Drowsiness=10;Tremor=3;Dry mouth=13;Constipation=6;Micturition=7;Diarrhea=6;Syncope/dizziness=11;Orthostatic effects=10;Dermatological=4,0.5909090909,active,phenelzine,NA,NA,NA,13,6,11,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Georgotas (1986) - 87999298,1986,28,,placebo,64.7,15,NA,NA,NA,NA,NA,7,NA,12,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Drowsiness=3;Tremor=0;Dry mouth=10;Constipation=3;Micturition=1;Diarrhea=4;Syncope/dizziness=10;Orthostatic effects=6;Dermatological=2,0.5357142857,placebo,placebo,NA,NA,NA,10,3,10,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Giller (1982) - 87999463,1982,NA,Isocarboxazid,isocarboxazid,NA,0,NA,48,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Covi Anxiety Scale Total,negative,13,10.2,1.4,Covi Anxiety Scale Total,negative,13,6.1,3.1,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,isocarboxazid,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Giller (1982) - 87999463,1982,NA,Placebo,placebo,NA,0,NA,73,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Covi Anxiety Scale Total,negative,11,9.5,1.6,Covi Anxiety Scale Total,negative,11,8.7,1.8,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1980) - 89913897,1980,52,Bupropion,bupropion,36.4,35,NA,NA,NA,150,450,6,28 months,16,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,42,20.7,6.48,HAM-A,negative,42,15.1,9,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Depressive Affect=51;Insomnia=52;Weight Loss=42;Headache=41;Sweating=27;Syncope/ Dizziness=18;Anorexia/ Decreased Appetite=29;Nausea/ Vomiting=29;Decreased Motor Activity=22;Excitement/ Agitation=26;Drowsiness=30;Dry Mouth=21;Constipation=23;Weight Gain=2,0.6730769231,active,bupropion 150-450mg,29,41,52,21,23,18,29,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1980) - 89913897,1980,23,Bupropion,bupropion,37.8,13,NA,NA,NA,300,900,6,28 months,10,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,14,21.3,8.23,HAM-A,negative,14,17.6,7.48,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Depressive Affect=21;Insomnia=20;Weight Loss=15;Headache=17;Sweating=16;Syncope/ Dizziness=15;Anorexia/ Decreased Appetite=13;Nausea/ Vomiting=12;Decreased Motor Activity=14;Excitement/ Agitation=14;Drowsiness=11;Dry Mouth=12;Constipation=10;Weight Gain=11,0.5652173913,active,bupropion 300-900mg,12,17,20,12,10,15,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1980) - 89913897,1980,47,Placebo,placebo,37.4,31,NA,NA,NA,NA,NA,6,28 months,10,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,40,22.7,5.69,HAM-A,negative,40,15.6,9.49,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Depressive Affect=45;Insomnia=43;Weight Loss=28;Headache=34;Sweating=23;Syncope/ Dizziness=12;Anorexia/ Decreased Appetite=24;Nausea/ Vomiting=17;Decreased Motor Activity=27;Excitement/ Agitation=21;Drowsiness=22;Dry Mouth=16;Constipation=14;Weight Gain=30,0.6595744681,placebo,placebo,17,34,43,16,14,12,17,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1985) - 89913880,1985,45,,bupropion,52.4,18,300,NA,300,300,300,4,NA,22,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Constipation=11;Tremor=7;Dry mouth=12;Insomnia=12;Excessive sweating=9;Sedation=8;Disturbed concentration=8;Blurred vision=8;Headache/migraine=5;Palpitations=6;Rash=6;Nausea/Vomiting=5;Urinary Frequency=6;Impaired Sleep Quality=6;Sensory Disturbance=3;Agitation=7;Confusion=4;Fatigue=6,0.4,active,bupropion 300mg,5,5,12,12,11,NA,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1985) - 89913880,1985,40,,bupropion,47.5,18,450,NA,450,450,450,4,NA,24,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Constipation=13;Tremor=13;Dry mouth=6;Insomnia=10;Excessive sweating=8;Sedation=9 Disturbed concentration=2;Blurred vision=5;Headache/migraine=6;Palpitations=6;Rash=4;Nausea/Vomiting=3;Urinary Frequency=1;Impaired Sleep;Quality=6;Sensory;Disturbance=5;Agitation=7;Confusion=7;Fatigue=1,0.45,active,bupropion 450mg,3,6,10,6,13,NA,3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1985) - 89913880,1985,43,Placebo,placebo,51.9,20,NA,NA,NA,NA,NA,4,NA,24,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAMD-21 Anxiety/Somatization Item,negative,39,1.64,0.43,HAMD-21 Anxiety/Somatization Item,negative,39,1.16,0.65,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Constipation=11;Tremor=4;Dry mouth=10;Insomnia=11;Excessive sweating=3;Sedation=8;Disturbed concentration=7;Blurred vision=4;Headache/migraine=9;Palpitations=4;Rash=3;Nausea/Vomiting=5;Urinary Frequency=3;Impaired Sleep Quality=2;Sensory Disturbance=5;Agitation=6;Confusion=7;Fatigue=6,0.4651162791,placebo,placebo,5,9,11,10,11,NA,5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1993) - 89913900,1993,119,*bupropion SR,bupropion,39.6,77,NA,NA,NA,100,100,8,"12 months. [{'ItemDocumentId': 1063758, 'TextFrom': 0, 'TextTo': 0, 'Text': 'Page 1:\n[¬s]""26 February 1992 – 25 February 1993[¬e]""', 'IsFromPDF': True, 'DocTitle': '853-v1.pdf', 'ItemArm': ''}]",38,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,112,17.3,6.2,HAM-A,negative,112,-7.2,6.6,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=45
Rhinitis=14
Dry Mouth=13
Insomnia=12
Nausea=12
Dizziness=9
Constipation=9
Pharyngitis=3",0.6470588235,active,bupropion sr 100mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1993) - 89913900,1993,120,Bupropion SR 200mg,bupropion,39.6,65,NA,NA,NA,NA,NA,8,"12 months. [{'ItemDocumentId': 1063758, 'TextFrom': 0, 'TextTo': 0, 'Text': 'Page 1:\n[¬s]""26 February 1992 – 25 February 1993[¬e]""', 'IsFromPDF': True, 'DocTitle': '853-v1.pdf', 'ItemArm': ''}]",42,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,114,17.4,5.9,HAM-A,negative,114,-6.6,6,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=35
Rhinitis=14
Dry Mouth=16
Insomnia=13
Nausea=13
Dizziness=17
Constipation=14
Pharyngitis=3",0.5416666667,active,bupropion sr 200mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1993) - 89913900,1993,120,*bupropion SR,bupropion,39.9,70,NA,NA,NA,300,300,8,"12 months. [{'ItemDocumentId': 1063758, 'TextFrom': 0, 'TextTo': 0, 'Text': 'Page 1:\n[¬s]""26 February 1992 – 25 February 1993[¬e]""', 'IsFromPDF': True, 'DocTitle': '853-v1.pdf', 'ItemArm': ''}]",51,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,111,18,6.4,HAM-A,negative,111,-6.2,7.7,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=31
Rhinitis=8
Dry Mouth=21
Insomnia=20
Nausea=15
Dizziness=6
Constipation=13
Pharyngitis=4",0.5833333333,active,bupropion sr 300mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1993) - 89913900,1993,119,*bupropion SR,bupropion,38.8,66,NA,NA,NA,400,400,8,"12 months. [{'ItemDocumentId': 1063758, 'TextFrom': 0, 'TextTo': 0, 'Text': 'Page 1:\n[¬s]""26 February 1992 – 25 February 1993[¬e]""', 'IsFromPDF': True, 'DocTitle': '853-v1.pdf', 'ItemArm': ''}]",43,12,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,111,17.3,5.8,HAM-A,negative,111,-5.6,7.2,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=29
Rhinitis=7
Dry Mouth=27
Insomnia=18
Nausea=20
Dizziness=13
Constipation=6
Pharyngitis=11",0.5546218487,active,bupropion sr 400mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1993) - 89913900,1993,124,Placebo,placebo,40.7,80,NA,NA,NA,NA,NA,8,"12 months. [{'ItemDocumentId': 1063758, 'TextFrom': 0, 'TextTo': 0, 'Text': 'Page 1:\n[¬s]""26 February 1992 – 25 February 1993[¬e]""', 'IsFromPDF': True, 'DocTitle': '853-v1.pdf', 'ItemArm': ''}]",39,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,116,18,6.1,HAM-A,negative,116,-5.8,6.6,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=42
Rhinitis=14
Dry Mouth=6
Insomnia=11
Nausea=10
Dizziness=10
Constipation=9
Pharyngitis=1",0.6451612903,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1994) - 89913899,1994,152,*bupropion SR,bupropion,39.1,90,50,NA,150,50,150,NA,14 months,33,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,146,16.33,4.88,HAM-A,negative,146,-7.74,6.55,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=34;
Dry mouth=21;
Nausea=18;
Rhinitis=15;
Flu syndrome=13;
Dizziness=11;
Consipation=10;
Insomnia=9;
Nervousness=8;
Tinnitus=7;
Dyspepsia=7;
Diarrhea=6;
Infection=4",0.5921052632,active,bupropion 50-150,18,34,9,21,10,11,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1994) - 89913899,1994,150,*bupropion SR,bupropion,37.2,98,100,NA,300,100,300,NA,14 months,47,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,144,16.34,4.72,HAM-A,negative,144,-6.9,6.51,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=38;
Dry mouth=25;
Nausea=22;
Rhinitis=6;
Flu syndrome=2;
Dizziness=11;
Consipation=14;
Insomnia=13;
Nervousness=9;
Tinnitus=10;
Dyspepsia=4;
Diarrhea=8;
Infection=12",0.6533333333,active,bupropion 100-300,22,38,13,25,14,11,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,GlaxoSmithKline (1994) - 89913899,1994,154,Placebo,placebo,38.2,99,NA,NA,NA,NA,NA,NA,14 months,48,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,148,16.58,5.45,HAM-A,negative,148,-6.39,6.55,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=27;
Dry mouth=14;
Nausea=12;
Rhinitis=17;
Flu syndrome=6;
Dizziness=9;
Consipation=9;
Insomnia=8;
Nervousness=5;
Tinnitus=3;
Dyspepsia=8;
Diarrhea=8;
Infection=10",0.6428571429,placebo,placebo,12,27,8,14,9,9,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Han (2012) - 87997489,2012,29,,bupropion,21.2,0,NA,NA,NA,150,300,8,12 weeks,4,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,active,bupropion,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Han (2012) - 87997489,2012,28,,placebo,18.1,0,NA,NA,NA,NA,NA,8,12 weeks,3,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Hewett (2009) - 87997883,2009,188,*Bupropion XR,bupropion,41.8,138,NA,170.1,NA,150,300,8,13 months,33,7,Motivation and Energy Inventory (MEI),positive,187,26.8,12.95,Motivation and Energy Inventory (MEI),positive,187,24.6,19.69,change,NA,HAM-A,negative,187,22,6.49,HAM-A,negative,187,-11.5,7.38,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=23;Dry mouth=16;Nausaea=11;Insomnia=10;Hyperhidrosis=7;Dizziness=7;Constipation=7;Nasopharyngitis=7;Abdominal pain, upper=6;Fatigue=5;Anxiety=5;Diarrhea=3;Somnolence=2;Anorexia=2;Influenza=0",0.7340425532,active,bupropion xr,11,23,10,16,7,7,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Hewett (2009) - 87997883,2009,199,Placebo,placebo,41.8,142,NA,NA,NA,NA,NA,8,13 months,30,10,Motivation and Energy Inventory (MEI),positive,197,26.4,12.79,Motivation and Energy Inventory (MEI),positive,197,17.4,19.37,change,NA,HAM-A,negative,197,21.8,6.7,HAM-A,negative,197,-9.8,7.58,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Headache=19;Dry mouth=11;Nausaea=21;Insomnia=4;Hyperhidrosis=2;Dizziness=14;Constipation=1;Nasopharyngitis=5;Abdominal pain, upper=6;Fatigue=4;Anxiety=9;Diarrhea=5;Somnolence=4;Anorexia=0;Influenza=5",0.7135678392,placebo,placebo,21,19,4,11,1,14,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Hewett (2010a) - 87997755,2010,203,,venlafaxine,44.1,127,NA,NA,NA,NA,NA,NA,14 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6256157635,active,venlafaxine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Hewett (2010a) - 87997755,2010,204,*Bupropion XR,bupropion,45.6,127,150,180,300,150,300,8,14 months,44,11,Motivation and Energy Inventory,positive,202,27.2,13.5,Motivation and Energy Inventory,positive,202,20.8,21.74,change,NA,HAM-A,negative,202,23,6.53,HAM-A,negative,202,-10.1,7,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Any adverse event=108;
Dry mouth=32;
Headache=30;
Nausea=27;
Insomnia=15;
Dizziness=14;
Hyperhidrosis=14;
Diarrhoea=8;
Fatigue=7;
Nasopharyngitis=7;
Upper abdominal pain=7;
Constipation=7;
Tremor=5;
Influenza=3;
Somnolence=3;
Anorexia=2",0.6225490196,active,bupropion xr,27,30,15,32,7,14,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Hewett (2010a) - 87997755,2010,189,Placebo,placebo,44.5,125,NA,NA,NA,NA,NA,8,14 months,41,11,Motivation and Energy Inventory,positive,186,25.3,12.81,Motivation and Energy Inventory,positive,186,18.3,21.95,change,NA,HAM-A,negative,186,23.6,6.81,HAM-A,negative,186,-8.8,9,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Any adverse event=112;
Dry mouth=13;
Headache=31;
Nausea=16;
Insomnia=8;
Dizziness=11;
Hyperhidrosis=7;
Diarrhoea=9;
Fatigue=13;
Nasopharyngitis=9;
Upper abdominal pain=8;
Constipation=3;
Tremor=2;
Influenza=9;
Somnolence=9;
Anorexia=2;",0.6613756614,placebo,placebo,16,31,8,13,3,11,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Hewett (2010b) - 87997769,2010,211,*Bupropion XR,bupropion,70.9,157,150,NA,300,150,300,10,15 months,48,17,Motivation and Energy Inventory (MEI),positive,210,29,13.85,Motivation and Energy Inventory (MEI),positive,210,23.6,22.89,change,NA,HAM-A,negative,210,20.4,5.47,HAM-A,negative,210,-8.1,6.67,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=20;Dry mouth=18;Nausea=14;Constipation=13;Insomnia=13;Dizziness=12;Hyperhidrosis=7;Nasopharyngitis=6;Fatigue=5;Diarrhea=4;Agitation=4;Anorexia=4;Back pain=4;Tinnitus=4;Restlessness=4;Tension=4;Chest pain=2;Depression=2,0.7440758294,active,bupropion xr,14,20,13,18,13,12,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Hewett (2010b) - 87997769,2010,207,Placebo,placebo,71.3,144,NA,NA,NA,NA,NA,10,15 months,46,22,Motivation and Energy Inventory (MEI),positive,204,29.5,15.16,Motivation and Energy Inventory (MEI),positive,204,16.9,23.42,change,NA,HAM-A,negative,204,20.3,5.68,HAM-A,negative,204,-7.3,6.71,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=22;Dry mouth=10;Nausea=17;Constipation=7;Insomnia=8;Dizziness=13;Hyperhidrosis=10;Nasopharyngitis=4;Fatigue=6;Diarrhea=6;Agitation=2;Anorexia=1;Back pain=1;Tinnitus=1;Restlessness=0;Tension=0;Chest pain=7;Depression=6,0.6956521739,placebo,placebo,17,22,8,10,7,13,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Iosifescu (2022) - 87996305,2022,163,,dextromethorphan-bupropion,42.1,95,NA,NA,NA,45,105,6,7 months,40,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Dizziness=26;
Nausea=21;
Headache=13;
Diarrhea=11;
Somnolence=11;
Dry mouth=9;
Hyperhidrosis=8;
Anxiety=7;
Constipation=3;
Decreased appetite=6;
Insomnia=6;
Upper respiratory tract infection=5;",0.608974359,active,dextromethorphan-bupropion,21,13,6,9,3,26,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Iosifescu (2022) - 87996305,2022,164,,placebo,41.2,117,NA,NA,NA,NA,NA,6,7 months,17,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Dizziness=10;
Nausea=14;
Headache=6;
Diarrhea=5;
Somnolence=5;
Dry mouth=4;
Hyperhidrosis=0;
Anxiety=2;
Constipation=3;
Decreased appetite=1;
Insomnia=3;
Upper respiratory tract infection=5;",0.7222222222,placebo,placebo,14,6,3,4,3,10,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Jarrett (1999) - 87998702,1999,36,,phenelzine,38.7,25,NA,NA,NA,NA,NA,8.8,10,9,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6944444444,active,phenelzine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Jarrett (1999) - 87998702,1999,36,,placebo,40.3,22,NA,NA,NA,NA,NA,10,10,23,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6111111111,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Jefferson (2006) - 87998173,2006,135,*Bupropion XR,bupropion,40,89,150,NA,450,150,450,8,12 months,32,12,IDS-C-30 (energy/pleasure/interest),negative,133,NA,NA,IDS-C-30 (energy/pleasure/interest),negative,133,-5.5,4.61,change,NA,IDS-C-30 (anxiety),negative,133,NA,NA,IDS-C-30 (anxiety),negative,133,-2,2.31,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=17;Dizziness=14;Nausea=14;Insomnia=10;Anxiety=8;Dyspepsia=7;Sinusitis=7;Tremor=0,0.6592592593,active,bupropion xr,14,NA,10,17,NA,14,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Jefferson (2006) - 87998173,2006,139,Placebo,placebo,39.8,96,NA,NA,NA,NA,NA,8,12 months,29,3,IDS-C-30 (energy/pleasure/interest),negative,137,NA,NA,IDS-C-30 (energy/pleasure/interest),negative,137,-3.7,4.61,change,NA,IDS-C-30 (anxiety),negative,137,NA,NA,IDS-C-30 (anxiety),negative,137,-1.6,2.34,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=8;Dizziness=3;Nausea=7;Insomnia=2;Anxiety=1;Dyspepsia=0;Sinusitis=3;Tremor=0,0.690647482,placebo,placebo,7,NA,2,8,NA,3,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Koshino (2013) - 87997374,2013,190,*bupropion SR,bupropion,36,92,150,NA,150,150,150,10,NA,30,12,MADRS item 8,negative,190,3.7,1.16,MADRS item 8,negative,190,2,1.45,endpoint,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Gastrointestinal disorders=47;Dry mouth=12;Nausea=13;Constipation=8;Infections and infestations=28;Nasopharyngitis=26;Nervous system disorders=29;Headache=16;Tremor=4;Psychiatric disorders=9;Insomnia=0,0.4842105263,active,bupropion 150mg,13,16,0,12,8,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Koshino (2013) - 87997374,2013,188,*bupropion SR,bupropion,37.5,83,300,NA,300,300,300,10,NA,9,12,MADRS item 8,negative,188,3.7,1.09,MADRS item 8,negative,188,2.1,1.55,endpoint,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Gastrointestinal disorders=63;Dry mouth=28;Nausea=16;Constipation=11;Infections and infestations=35;Nasopharyngitis=29;Nervous system disorders=37;Headache=19;Tremor=9;Psychiatric disorders=18;Insomnia=10,0.4414893617,active,bupropion 300mg,16,19,10,28,11,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Koshino (2013) - 87997374,2013,186,Placebo,placebo,37.9,85,NA,NA,NA,NA,NA,10,NA,22,4,MADRS item 8,negative,186,3.7,1.06,MADRS item 8,negative,186,2,1.45,endpoint,8,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Gastrointestinal disorders=39;Dry mouth=8
Nausea=15;Constipation=3;Infections and infestations=42;Nasopharyngitis=35;Nervous system disorders=29;Headache=13;Tremor=0;Psychiatric disorders=14;Insomnia=6",0.4569892473,placebo,placebo,15,13,6,8,3,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Kusalic (1993) - 87999015,1993,11,,moclobemide,NA,NA,NA,482.6,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,moclobemide,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Kusalic (1993) - 87999015,1993,9,,placebo,NA,NA,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Larsen (1989) - 87999196,1989,22,,moclobemide,51,15,NA,NA,300,NA,300,6,NA,6,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dizziness=2;Tremor=0;Anticholinergic symptoms=3,0.6818181818,active,moclobemide,NA,NA,NA,NA,NA,2,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Larsen (1989) - 87999196,1989,18,,placebo,57,12,NA,NA,NA,NA,NA,6,NA,5,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dizziness=3;Tremor=0;Anticholinergic symptoms=3,0.6666666667,placebo,placebo,NA,NA,NA,NA,NA,3,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Learned (2012a) - 90047003,2012,134,*GSK372475,gsk372475,43,51,1,NA,2,1.5,2,10,20 months,69,19,NA,NA,NA,NA,NA,Motivation and Energy Inventory (MEI),positive,NA,NA,NA,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=31;Headache=28;Nausea=18;Insomnia=16;Dizziness=13;Constipation=14;Tachycardia=14;Anxiety=13;Diarrhea=1;Hyperhidrosis=10;Palpitations=8;Dyspepsia=8;Somnolence=7 Decreased appetite=7;Agitation=7,0.3805970149,active,gsk372475,18,28,16,31,14,13,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Learned (2012a) - 90047003,2012,126,Placebo,placebo,41.9,46,NA,NA,NA,NA,NA,10,20 months,42,7,NA,NA,NA,NA,NA,Motivation and Energy Inventory (MEI),positive,126,26.5,23.12,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=5;Headache=24;Nausea=14;Insomnia=11;Dizziness=11;Constipation=9;Tachycardia=4;Anxiety=5;Diarrhea=8;Hyperhidrosis=3;Palpitations=2;Dyspepsia=2;Somnolence=3;Decreased appetite=1;Agitation=4;,0.3650793651,placebo,placebo,14,24,11,5,9,11,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Learned (2012b) - 91551222,2012,171,*GSK372475,gsk372475,42.4,54,1,NA,1.5,1,1.5,10,19 months,71,25,Motivation and Energy Inventory (MEI),positive,NA,NA,NA,Motivation and Energy Inventory (MEI),positive,NA,NA,NA,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=38;Headache=35;Nausea=18;Insomnia=17;Dizziness=17;Constipation=16;Tachycardia=12;Diarrhea=10;Sleep Disorder=10;Hyperhidrosis=9;Palpitations=9,0.3157894737,active,gsk372475,18,35,17,38,16,17,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Learned (2012b) - 91551222,2012,156,Placebo,placebo,41.8,39,NA,NA,NA,NA,NA,10,19 months,41,3,Motivation and Energy Inventory (MEI),positive,156,NA,NA,Motivation and Energy Inventory (MEI),positive,156,NA,NA,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=4;Headache=36;Nausea=12;Insomnia=8;Dizziness=7;Constipation=8;Tachycardia=1;Diarrhea=9;Sleep Disorder=3;Hyperhidrosis=5;Palpitations=3,0.25,placebo,placebo,12,36,8,4,8,7,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Liebowitz (1984) - 87999380,1984,15,Phenelzine,phenelzine,33.8,7,60,74,90,15,90,6,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HSC - anxiety scale,negative,14,1,0.6,HSC - anxiety scale,negative,12,0.9,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4666666667,active,phenelzine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Liebowitz (1984) - 87999380,1984,24,Placebo,placebo,37.7,14,NA,NA,NA,NA,NA,6,NA,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HSC - anxiety scale,negative,22,1.6,1,HSC - anxiety scale,negative,18,1.5,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5833333333,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Mann (1989) - 87999225,1989,22,,selegiline,45.2,16,NA,NA,50,NA,NA,6,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Orthostatic symptoms=1;Sexual dysfunction=2;Myoclonic jerks=1;Insomnia=3;Dizziness=5;Dry mouth=9;Constipation=4;Drowsiness=7;Hyperactivity=1;Blurry vision=4;Tremor=7;Headache=7;Nausea=6;Other=10,0.7272727273,active,selegiline,6,7,3,9,4,5,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Mann (1989) - 87999225,1989,22,,placebo,40.2,17,NA,NA,NA,NA,NA,6,NA,7,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Orthostatic symptoms=0;Sexual dysfunction=1;Myoclonic jerks=0;Insomnia=0;Dizziness=6;Dry mouth=5;Constipation=3;Drowsiness=3;Hyperactivity=4;Blurry vision=1;Tremor=3;Headache=11;Nausea=4;Other=8,0.7727272727,placebo,placebo,4,11,0,5,3,6,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Nair (1995) - 87998891,1995,36,,moclobemide,NA,25,NA,NA,400,400,400,7,39 months,21,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"CNS=20
Anticholinergic=13
Orthostatic=8
Cardiovascular=2
Gastrointestinal tract=8
Skin=2
Musculoskeletal system=4
Respiratory system=2
Other=8",0.6944444444,active,moclobemide,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Nair (1995) - 87998891,1995,35,,placebo,NA,25,NA,NA,NA,NA,NA,7,39 months,15,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,CNS=17;Anticholinergic=17;Orthostatic=9;Cardiovascular=3;Gastrointestinal tract=9;Skin=4;Musculoskeletal system=3;Respiratory system=1;Other=14,0.7142857143,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Ose (1992) - 87999057,1992,35,,moclobemide,NA,21,300,NA,500,300,500,4,NA,16,5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"agitation=4;
restlessness=3;
weight loss=2;
dizziness=1;
headache=1;
dyspepsia=1;
hypotension=1;
insomnia=1;
fainting=1;",0.6,active,moclobemide,NA,1,1,NA,NA,1,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Ose (1992) - 87999057,1992,33,,placebo,NA,18,NA,NA,NA,NA,NA,NA,NA,12,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"agitation=1;
restlessness=1;
weight loss=1;
headache=1;
dyspepsia=1;
insomnia=1;",0.5454545455,placebo,placebo,NA,1,1,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Parnetti (1993) - 90055317,1993,63,Minaprine,minaprine,71.6,36,200,200,200,200,200,12.85714286,3 months,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SRT Anxiety Subscale,negative,59,6.9,4,SRT Anxiety Subscale,negative,59,5.2,3.8,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"nausea=1;
dry mouth=1;
restlessness=1;",0.5714285714,active,minipramine,1,NA,NA,1,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Parnetti (1993) - 90055317,1993,67,Placebo,placebo,71.3,47,NA,NA,NA,NA,NA,12.85714286,3 months,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SRT Anxiety Subscale,negative,64,6.7,3.7,SRT Anxiety Subscale,negative,64,6.1,4.1,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"nausea=1;
mild to moderate rash=1;
diplopia=1;",0.7014925373,placebo,placebo,1,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Quitkin (1990) - 87999150,1990,33,Phenelzine,phenelzine,38.9,NA,45,NA,90,90,90,6,NA,3,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SCL-90 Anxiety subscale,negative,27,2.2,NA,SCL-90 Anxiety subscale,negative,27,1.6,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,phenelzine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Quitkin (1990) - 87999150,1990,34,Placebo,placebo,30.1,NA,NA,NA,NA,NA,NA,6,NA,8,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SCL-90 Anxiety subscale,negative,23,2.2,NA,SCL-90 Anxiety subscale,negative,23,2.1,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Raft (1981) - 87999485,1981,NA,,phenelzine,NA,NA,30,90,90,90,90,5,6,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dizziness=2;nausea=1;drowsiness=2;excessive weight gain=4,NA,active,phenelzine,1,NA,NA,NA,NA,2,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Raft (1981) - 87999485,1981,NA,,placebo,NA,NA,NA,NA,NA,NA,NA,5,6,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,dizziness=2;chest pain=1;forgetfulness=2,NA,placebo,placebo,NA,NA,NA,NA,NA,2,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Rampello (1991) - 90055414,1991,10,,minaprine,NA,NA,100,NA,200,100,NA,6,6,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,minaprine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Rampello (1991) - 90055414,1991,10,,placebo,NA,NA,NA,NA,NA,NA,NA,6,6,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Raskin (1972) - 87999631,1972,110,,phenelzine,NA,72,22.5,NA,45,45,45,5,7 weeks,NA,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"severe headaches=1;dizziness and faintness=1;Exfoliative dermatitis, gravitational swelling, burning pain, liver enlargement=1",0.6545454545,active,phenelzine,NA,1,NA,NA,NA,1,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Raskin (1972) - 87999631,1972,111,,placebo,NA,NA,NA,NA,NA,NA,NA,NA,7 weeks,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Ravaris (1976) - 87999576,1976,21,Phenelzine,phenelzine,43.1,NA,60,NA,60,60,60,6,NA,6,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SHID - anxiety total subscale,negative,14,22.1,8.61,SHID - anxiety total subscale,negative,14,12.1,NA,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,phenelzine 60mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Ravaris (1976) - 87999576,1976,21,Phenelzine,phenelzine,41.2,NA,30,NA,30,30,30,5,NA,5,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SHID - anxiety total subscale,negative,16,17.9,6,SHID - anxiety total subscale,negative,16,6,NA,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,phenelzine 30mg,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Ravaris (1976) - 87999576,1976,21,Placebo,placebo,38.9,NA,NA,NA,NA,NA,NA,6,NA,2,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,SHID - anxiety total subscale,negative,19,19.6,7.41,SHID - anxiety total subscale,negative,19,6.5,NA,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Reimherr (1998) - 87998734,1998,121,*bupropion SR,bupropion,38.3,86,150,NA,150,150,150,8,12,55,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,120,16.88,4.81,HAM-A,negative,120,-6.8,6.5,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=26;Dry Mouth=16;Sweating=5;Constipation=6;Nausea=11;Infection=4;Insomnia=9;Tremor=4;Dizziness=7;Dyspepsia=3;Nervousness=5;Anxiety=8;Rash=5;Diarrhea=2;Rhinitis=9;Flu Syndrome=6;Myalgia=2,0.7107438017,active,bupropion sr 150mg,11,26,9,16,6,7,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Reimherr (1998) - 87998734,1998,120,*bupropion SR,bupropion,38.6,92,300,NA,300,300,300,8,12,53,13,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,113,17.89,5.07,HAM-A,negative,113,-7.58,5.95,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=28;Dry Mouth=19;Sweating=13;Constipation=12;Nausea=12 Infection=10;Insomnia=10;Tremor=10;Dizziness=8;Dyspepsia=6;Nervousness=6;Anxiety=5;Rash=5;Diarrhea=4;Rhinitis=4;Flu Syndrome=3;Myalgia=2,0.7666666667,active,bupropion sr 300mg,12,28,10,19,12,8,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Reimherr (1998) - 87998734,1998,121,Placebo,placebo,40.2,69,NA,NA,NA,NA,NA,8,12,60,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,116,17.39,4.22,HAM-A,negative,116,-5.78,6.89,change,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Headache=21;Dry Mouth=7;Sweating=2;Constipation=8;Nausea=7;Infection=6;Insomnia=6;Tremor=0;Dizziness=2;Dyspepsia=4;Nervousness=4;Anxiety=5;Rash=2;Diarrhea=5;Rhinitis=6;Flu Syndrome=1;Myalgia=5,0.5702479339,placebo,placebo,7,21,6,7,8,2,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Rickels (1970) - 89913734,1970,NA,,methylphenidate,NA,NA,15,NA,15,15,15,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,stimulation=11; mild sedation=1;nausea=1;vomiting=1;dizziness=1;vertigo=1,NA,active,methylphenidate,1,NA,NA,NA,NA,1,1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Rickels (1970) - 89913734,1970,NA,,placebo,NA,NA,NA,NA,NA,NA,NA,4,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Itching skin=1;nervousness=1;sedation=2;stimulation=4,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Riesenberg (2010) - 90051999,2010,21,,rx-10100,44.8,11,5,NA,5,5,5,8,NA,3,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Gastrointestinal disorders=3; Constipation=2; Dyspepsia=1; General disorders and administration site conditions=2; pain=0; Injury, poisoning and procedural complications=1; Muscle strain=1; Investigations=4; Blood bilirubin increased=1; Blood creatine phosphokinase increased=1; Blood pressure increased=1; Musculoskeletal and connective tissue disorders=0; Myalgia=0; Nervous system disorders=4; Headache=3; Psychiatric disorders=1; Agitation=1",0.5238095238,active,rx-10100 5mg,NA,3,NA,NA,2,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Riesenberg (2010) - 90051999,2010,16,,rx-10100,42.6,7,10,NA,10,10,10,8,NA,6,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Gastrointestinal disorders=5; Constipation=1; Dyspepsia=0; General disorders and administration site conditions=2; pain=2; Injury, poisoning and procedural complications=2; Muscle strain=1; Investigations=2; Blood bilirubin increased=0; Blood creatine phosphokinase increased=1; Blood pressure increased=1; Musculoskeletal and connective tissue disorders=2; Myalgia=0; Nervous system disorders=6; Headache=4; Psychiatric disorders=2; Agitation=1",0.4375,active,rx-10100 10mg,NA,4,NA,NA,1,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Riesenberg (2010) - 90051999,2010,17,,rx-10100,39.4,9,15,NA,15,15,15,8,NA,1,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Gastrointestinal disorders=3; Constipation=0; Dyspepsia=1; General disorders and administration site conditions=0; pain=0; Injury, poisoning and procedural complications=1; Muscle strain=0; Investigations=3; Blood bilirubin increased=1; Blood creatine phosphokinase increased=1; Blood pressure increased=0; Musculoskeletal and connective tissue disorders=2; Myalgia=2; Nervous system disorders=1; Headache=0; Psychiatric disorders=4; Agitation=0",0.5294117647,active,rx-10100 15mg,NA,0,NA,NA,0,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Riesenberg (2010) - 90051999,2010,21,,placebo,42.5,11,NA,NA,NA,NA,NA,8,NA,13,3,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Gastrointestinal disorders=5; Constipation=0; Dyspepsia=0; General disorders and administration site conditions=2; pain=0; Injury, poisoning and procedural complications=1; Muscle strain=0; Investigations=2; Blood bilirubin increased=0; Blood creatine phosphokinase increased=0; Blood pressure increased=0; Musculoskeletal and connective tissue disorders=4; Myalgia=0; Nervous system disorders=3; Headache=0; Psychiatric disorders=3; Agitation=0",0.5238095238,placebo,placebo,NA,0,NA,NA,0,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,ROBIN (1958) - 87999692,1958,22,,methylphenidate,37.5,16,NA,NA,NA,20,40,4,NA,5,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7272727273,active,methylphenidate,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,ROBIN (1958) - 87999692,1958,23,,placebo,39.5,13,NA,NA,NA,NA,NA,4,NA,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5652173913,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Rowan (1980) - 87999511,1980,NA,,phenelzine,NA,NA,NA,NA,NA,45,75,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,phenelzine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Rowan (1980) - 87999511,1980,NA,,placebo,NA,NA,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Tomarken (2004) - 87998395,2004,10,*bupropion SR,bupropion,39.4,6,100,NA,400,300,400,6,NA,1,NA,MASQ Anhedonia,negative,10,NA,0,MASQ Anhedonia,negative,10,NA,NA,endpoint,NA,"MASQ - anxiety ",negative,10,NA,NA,"MASQ - anxiety ",negative,10,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6,active,bupropion sr,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Tomarken (2004) - 87998395,2004,9,Placebo,placebo,37.5,6,NA,NA,NA,NA,NA,6,NA,0,NA,MASQ Anhedonia,negative,9,NA,NA,MASQ Anhedonia,negative,9,NA,NA,endpoint,NA,"MASQ - anxiety ",negative,9,NA,NA,"MASQ - anxiety ",negative,9,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Ucha (1990) - 87999157,1990,24,,moclobemide,40.5,16,NA,NA,NA,300,600,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.6666666667,active,moclobemide,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Ucha (1990) - 87999157,1990,24,,placebo,42.2,13,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5416666667,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Versiani (1989) - 89956243,1989,164,,moclobemide,44,124,NA,NA,NA,300,600,6,NA,43,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.756097561,active,moclobemide,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Versiani (1989) - 89956243,1989,162,,placebo,42,123,NA,NA,NA,NA,NA,6,NA,58,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.7592592593,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Versiani (1990) - 87999137,1990,25,,moclobemide,NA,NA,600,600,600,600,600,6,NA,5,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,moclobemide,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Versiani (1990) - 87999137,1990,25,,placebo,NA,NA,NA,NA,NA,NA,NA,6,NA,3,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Versiani (1997) - 87998762,1997,108,,moclobemide,41,73,75,633,750,75,750,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=38;Tremor=8;Constipation=11;Sweating=5;Blurred vision=5;Sleepiness=12;Dizziness=19;Headache=21;Insomnia=19;Nausea=19,0.6759259259,active,moclobemide,19,21,19,38,11,19,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Versiani (1997) - 87998762,1997,104,,placebo,40,71,NA,NA,NA,NA,NA,6,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,Dry mouth=21;Tremor=7;Constipation=15;Sweating=1;Blurred vision=4;Sleepiness=12;Dizziness=10;Headache=12;Insomnia=21;Nausea=20,0.6826923077,placebo,placebo,20,12,21,21,15,10,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,White (1984) - 87999366,1984,63,Tranylcypromine,tranylcypromine,38,14,NA,44.4,NA,30,60,4,NA,26,12,Zung - anhedonia,negative,37,NA,NA,Zung - anhedonia,negative,37,NA,NA,endpoint,NA,NPRL - anxiety,negative,37,NA,NA,NPRL - anxiety,negative,37,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Dizziness=24;
Sedation=14;
Insomnia=20;
Dry Mouth=26;
Constipation=5;
Blurred vision=5;
Confusion=1;
Headache=11;
Overexcitement=9;
Tremor=4",0.2222222222,active,tranylcypromine,NA,11,20,26,5,24,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,White (1984) - 87999366,1984,61,,nortriptyline,35,20,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.3278688525,active,nortriptyline,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,White (1984) - 87999366,1984,59,Placebo,placebo,39,21,NA,NA,NA,NA,NA,4,NA,14,NA,Zung - anhedonia,negative,40,NA,NA,Zung - anhedonia,negative,40,NA,NA,endpoint,NA,NPRL - anxiety,negative,40,NA,NA,NPRL - anxiety,negative,40,NA,NA,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,"Dizziness=6;
Sedation=11;
Insomnia=4;
Dry Mouth=9;
Constipation=3;
Blurred vision=3;
Confusion=1;
Headache=8;
Overexcitement=3;
Tremor=1",0.3559322034,placebo,placebo,NA,8,4,9,3,6,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Zarate (2006) - 87998230,2006,16,Memantine,memantine,47.1,9,5,19.4,20,5,20,8,NA,3,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,HAM-A,negative,13,0.42,0,endpoint,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.5625,active,memantine,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Zarate (2006) - 87998230,2006,16,,placebo,46.1,7,NA,NA,NA,NA,NA,8,NA,3,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0.4375,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Zisook (1985) - 87999335,1985,NA,,isocarboxazid,NA,NA,NA,39,NA,NA,80,6,6 weeks,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,active,isocarboxazid,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1,Zisook (1985) - 87999335,1985,NA,,placebo,NA,NA,NA,NA,NA,NA,NA,6,6 weeks,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,placebo,placebo,NA,NA,NA,NA,NA,NA,NA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
3,Isaacson (2023),,,,,70.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront,1,parallel-RCT,ulotaront,47.5,Parkinson Disease Psychosis,acute,39,25,4,6,6,16,,,10,25,5,25,0,25,2,25,Low,Low,High,Low,Low,High,NPI total,23,,-11.5,20.12,change,no,yes,SAPS-PD,24,13.1,-2.5,7.94,change,no,yes,,,,,,,,,,,,,,,,,MMSE,23,-25.1,0.8,2.2,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,18,25,,,,,4,25,,,3,25,2,25,,,,,,,13,25,2,,,,,,,,TAAR1 agonist,3-13 weeks,yes
3,Isaacson (2023),,,,,70.7,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,1,parallel-RCT,placebo,0,Parkinson Disease Psychosis,acute,39,14,1,6,3,11,,,3,14,1,14,0,14,0,14,Low,Low,High,Low,Low,High,NPI total,14,,-17.3,19.57,change,no,yes,SAPS-PD,14,14.7,-1.4,7.71,change,no,yes,,,,,,,,,,,,,,,,,MMSE,14,-24.7,-0.3,1.99,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,12,14,,,0,14,1,14,,,1,14,2,14,,,,,1,14,11,14,1,14,,,,,,,placebo,3-13 weeks,yes
3,Koblan (2020),,,,,30.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront,1,parallel-RCT,ulotaront,50-75,Schizophrenia spectrum,acute,245,120,43,4,78,120,,,26,120,10,120,1,120,2,120,Low,Low,Some concerns,Low,Low,Low,PANSS total,120,101.4,-17.2,18.63,change,no,yes,PANSS positive,120,25.8,-5.5,5.48,change,no,yes,PANSS negative,120,24.7,-3.1,4.38,change,no,yes,,,,,,,,,,,,,,,,,MADRS,120,13.1,-3.3,6.57,change,no,yes,weight kg,120,75.4,0.3,1.9,change,no,yes,4 weeks,prolactin levels ng/ml,114,,-1.965789474,28,change,yes,no,55,120,,,2,120,,,11,120,6,120,8,120,,,0,120,6,120,,,4,120,1,120,4,120,1,120,TAAR1 agonist,3-13 weeks,yes
3,Koblan (2020),,,,,30.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,1,parallel-RCT,placebo,0,Schizophrenia spectrum,acute,245,125,46,4,55,125,,,26,125,8,125,0,125,4,125,Low,Low,Some concerns,Low,Low,Low,PANSS total,125,99.7,-9.7,17.89,change,no,yes,PANSS positive,125,25.4,-3.9,5.59,change,no,yes,PANSS negative,125,24.9,-1.6,4.47,change,no,yes,,,,,,,,,,,,,,,,,MADRS,125,12.6,-1.6,6.71,change,no,yes,weight kg,125,75.4,-0.1,2.3,change,no,yes,4 weeks,prolactin levels ng/ml,113,,-1.38380531,28,change,yes,no,63,125,,,9,125,,,15,125,4,125,6,125,,,0,125,6,125,,,13,125,0,125,4,125,1,125,placebo,3-13 weeks,yes
3,NCT04072354 (2019),,,,,>18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 50mg/d (adults),1,parallel-RCT,ulotaront,50,Schizophrenia spectrum,acute,435,144,,6,22,144,,,34,144,,,,,,,Low,Low,Some concerns,Low,Low,Low,PANSS total,142,102,-16.9,19.07,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TAAR1 agonist,3-13 weeks,yes
3,NCT04072354 (2019),,,,,>18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 75mg/d (adults),1,parallel-RCT,ulotaront,75,Schizophrenia spectrum,acute,435,145,,6,29,145,,,27,145,,,,,,,Low,Low,Some concerns,Low,Low,Low,PANSS total,145,102,-19.6,19.27,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TAAR1 agonist,3-13 weeks,yes
3,NCT04072354 (2019),,,,,>18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo (adults),1,parallel-RCT,placebo,0,Schizophrenia spectrum,acute,435,146,,6,26,146,,,27,146,,,,,,,Low,Low,Some concerns,Low,Low,Low,PANSS total,145,102,-19.3,18.06,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,3-13 weeks,yes
3,NCT04092686 (2019),,,,,>18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 75mg/d,1,parallel-RCT,ulotaront,75,Schizophrenia spectrum,acute,464,155,,6,23,155,,,34,155,,,,,,,Low,Low,Some concerns,Low,Low,Low,PANSS total,153,101,-16.4,18.55,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TAAR1 agonist,3-13 weeks,yes
3,NCT04092686 (2019),,,,,>18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 100mg/d,1,parallel-RCT,ulotaront,100,Schizophrenia spectrum,acute,464,154,,6,27,154,,,38,154,,,,,,,Low,Low,Some concerns,Low,Low,Low,PANSS total,152,100,-18.1,18.49,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TAAR1 agonist,3-13 weeks,yes
3,NCT04092686 (2019),,,,,>18,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,1,parallel-RCT,placebo,0,Schizophrenia spectrum,acute,464,155,,6,21,155,,,27,155,,,,,,,Low,Low,Some concerns,Low,Low,Low,PANSS total,155,100,-14.3,18.67,change,no,yes,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,3-13 weeks,yes
3,NCT04512066 (2020),,,,,33.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo (P2; 4 weeks),1,parallel-RCT,placebo,0,Schizophrenia spectrum,acute,287,73,19,4,6,72,,,17,73,6,73,0,72,1,72,Low,Low,Some concerns,Low,Low,Low,PANSS total,54,99.38,88.69,20.18,endpoint,yes,yes,PANSS positive,54,26.86,23.61,6.64,endpoint,yes,yes,PANSS negative,54,24.1,22.65,5.81,endpoint,yes,yes,,,,,,,,,,,,,,,,,PANSS anxiety/depression,54,11.58,9.56,4.03,endpoint,yes,yes,,,,,,,,,,,,,,,,,,23,72,,,6,72,,,4,72,4,72,,,,,,,2,72,,,1,72,,,,,1,72,placebo,3-13 weeks,yes
3,NCT04512066 (2020),,,,,33.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ralmitaront 45mg (P2; 4 weeks),1,parallel-RCT,ralmitaront,45,Schizophrenia spectrum,acute,287,71,19,4,5,65,,,16,71,4,71,0,65,2,65,Low,Low,Some concerns,Low,Low,Low,PANSS total,49,98.54,88.94,17.03,endpoint,yes,yes,PANSS positive,49,26.2,23.41,6.14,endpoint,yes,yes,PANSS negative,49,23.65,21.82,5.85,endpoint,yes,yes,,,,,,,,,,,,,,,,,PANSS anxiety/depression,49,12.91,9.88,4.15,endpoint,yes,yes,,,,,,,,,,,,,,,,,,14,65,,,3,65,,,4,65,0,65,,,,,,,0,65,,,3,65,,,,,2,65,TAAR1 agonist,3-13 weeks,yes
3,NCT04512066 (2020),,,,,33.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ralmitaront 150mg (P2; 4 weeks),1,parallel-RCT,ralmitaront,150,Schizophrenia spectrum,acute,287,69,15,4,6,68,,,16,69,5,69,0,68,1,68,Low,Low,Some concerns,Low,Low,Low,PANSS total,51,100.53,85.18,17.67,endpoint,yes,yes,PANSS positive,51,27.26,22.22,6.5,endpoint,yes,yes,PANSS negative,51,24.59,22.53,5.41,endpoint,yes,yes,,,,,,,,,,,,,,,,,PANSS anxiety/depression,51,11.54,9.06,4.08,endpoint,yes,yes,,,,,,,,,,,,,,,,,,23,68,,,2,68,,,5,68,2,68,,,,,,,8,68,,,5,68,,,,,0,68,TAAR1 agonist,3-13 weeks,yes
3,NCT04512066 (2020),,,,,33.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,risperidone (P2; 4 weeks),1,parallel-RCT,risperidone,4,Schizophrenia spectrum,acute,287,74,18,4,10,71,,,14,74,1,74,0,71,0,71,Low,Low,Some concerns,Low,Low,Low,PANSS total,56,100.03,78.04,15.78,endpoint,yes,yes,PANSS positive,56,27.49,19.52,5.11,endpoint,yes,yes,PANSS negative,56,23.65,21.45,5.13,endpoint,yes,yes,,,,,,,,,,,,,,,,,PANSS anxiety/depression,56,12.58,8.5,4.09,endpoint,yes,yes,,,,,,,,,,,,,,,,,,36,71,,,5,71,,,6,71,6,71,,,,,,,0,71,,,5,71,,,,,8,71,D2 antipsychotic,3-13 weeks,yes
3,Perini (2023),,,,,29.2,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo (LS and HS),1,parallel-RCT,placebo,0,Healthy volunteers,,105,34,18,0.14,,,,,2,34,0,34,0,34,0,34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,16,34,0,34,0,34,2,34,7,34,0,34,5,34,,,,,,,,,,,,,,,,,placebo,1 day-2 weeks,yes
3,Perini (2023),,,,,27.4,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront (LS and HS),1,parallel-RCT,ulotaront,50,Healthy volunteers,,105,35,14,0.14,,,,,5,35,0,35,0,35,1,35,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,34,35,5,35,0,35,10,35,4,35,12,35,21,35,,,,,,,,,,,,,,,,,TAAR1 agonist,1 day-2 weeks,yes
3,Perini (2023),,,,,27.6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,amisulpride (LS and HS),1,parallel-RCT,amisulpride,400,Healthy volunteers,,105,36,13,0.14,,,,,2,36,0,36,0,36,0,36,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,15,36,0,36,3,36,1,36,1,36,0,36,5,36,,,,,,,,,,,,,,,,,D2 antipsychotic,1 day-2 weeks,yes
3,Tsukada (2023),,,,,48.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,1,crossover-RCT,placebo,0,Schizophrenia spectrum,stable,68,68,15,0.14,,,,,,,1,63,0,63,0,63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,63,,,,,1,63,,,1,63,0,63,,,1,59,,,,,,,,,,,,,placebo,1 day-2 weeks,yes
3,Tsukada (2023),,,,,48.3,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 150mg,1,crossover-RCT,ulotaront,150,Schizophrenia spectrum,stable,68,68,15,0.14,,,,,0,63,0,63,0,63,1,63,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,32,63,,,,,7,63,,,16,63,16,63,,,5,62,,,,,,,,,,,,,TAAR1 agonist,1 day-2 weeks,yes
3,Hopkins (2021),,,,,25.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 10mg,1,crossover-RCT,ulotaront,10,Healthy volunteers,,24,12,0,0.14,,,,,0,12,0,12,0,12,0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,12,,,,,,,,,1,12,0,12,0,12,0,12,,,,,,,,,,,,,TAAR1 agonist,1 day-2 weeks,yes
3,Hopkins (2021),,,,,25.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 50mg,1,crossover-RCT,ulotaront,50,Healthy volunteers,,24,12,0,0.14,,,,,0,12,0,12,0,12,0,12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,12,,,,,,,,,0,12,1,12,0,12,0,12,,,,,,,,,,,,,TAAR1 agonist,1 day-2 weeks,yes
3,Hopkins (2021),,,,,25.1,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,1,crossover-RCT,placebo,0,Healthy volunteers,,24,24,0,0.14,,,,,0,24,0,24,0,24,0,24,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,24,,,,,,,,,0,24,0,24,0,24,0,24,,,,,,,,,,,,,placebo,1 day-2 weeks,yes
3,Szabo (2023),,,,,32.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 50mg,1,crossover-RCT,ulotaront,50,Narcolepsy-cataplexy,,16,16,12,2,,,,,,,,,0,16,0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,6,15,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TAAR1 agonist,1 day-2 weeks,yes
3,Szabo (2023),,,,,32.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,ulotaront 25mg,0,crossover-RCT,ulotaront,25,Narcolepsy-cataplexy,,16,16,12,2,,,,,,,,,0,16,0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,1,13,,,,,,,,,,,,,,,,,,,,,,,,,,,,,TAAR1 agonist,1 day-2 weeks,yes
3,Szabo (2023),,,,,32.9,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,1,crossover-RCT,placebo,0,Narcolepsy-cataplexy,,16,16,12,2,,,,,,,,,0,16,0,16,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,2,14,,,,,,,,,,,,,,,,,,,,,,,,,,,,,placebo,1 day-2 weeks,yes
